bliss gvs pharma has accepted the resignation of Sachin Saboo, General Manager – Regulatory and Clinical, effective July 24, 2026. The Mumbai-based pharmaceutical manufacturer disclosed the departure to the National Stock Exchange of India Limited and BSE Limited on July 24, 2026. Saboo, identified as Senior Management Personnel under SEBI regulations, submitted his resignation letter on April 30, 2026, citing an intent to move in a direction that aligns more closely with his professional aspirations. This change marks an exit from a key regulatory role within the company’s senior management structure.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III. The filing also referenced SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Aditi Bhatt, Company Secretary, signed the intimation letter addressed to the listing departments of both exchanges.

Resignation Details

The company confirmed that Saboo was relieved from his duties at the close of business hours on July 24, 2026. His resignation letter, dated April 30, 2026, expressed appreciation for the support received from management and colleagues during his tenure. Saboo committed to ensuring a smooth transition of responsibilities during his notice period.

The filing did not disclose any relationships between directors or provide a brief profile beyond the designation. The company stated that the resignation was voluntary and based on personal career considerations.

Bliss GVS Pharma Limited shareholders approved the declaration of a final dividend of ₹1.00 per equity share for the financial year ended March 31, 2026, at its 41st Annual General Meeting held on July 15, 2026. The meeting, conducted via video conferencing, also saw the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO and the adoption of the audited financial statements for FY26. The voting results were disclosed to the stock exchanges in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Outcomes

All three ordinary resolutions presented at the AGM were passed. The adoption of the audited standalone and consolidated financial statements received 99.99% approval, with 65,393,771 votes in favour and 3,098 against. The resolution to declare the final dividend of 100%, or ₹1.00 per share on a face value of ₹1 each, was approved with 100% of votes polled in favour. The re-appointment of Mr. Narsimha Shibroor Kamath (DIN: 00140593) as Managing Director & CEO was approved by 97.68% of the votes polled, with Public Institutions holding 14.45% of their votes against the resolution.

Procedural Details

The remote e-voting process commenced on July 12, 2026, and concluded on July 14, 2026, facilitated by Central Depository Services (India) Limited (CDSL). Mr. Vijay Yadav, Partner of AVS & Associates, served as the Scrutinizer for the meeting. The record date for determining shareholder eligibility was July 08, 2026, with a total of 47,336 shareholders on record. The meeting was chaired by Mr. Nandkumar Chodankar, Chairman & Independent Director.